Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cras

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Brain : a Journal of Neurology|December 18, 2015
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohortSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Neurology|November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohortIlse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Acta Neurologica Belgica|October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical AssociationJan Versijpt, Mark Tant, Ingo Beyer, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Archives of Neurology|October 10, 2007
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder familyNathalie Brouwers, Karen Nuytemans, Julie van der Zee, et al.
Journal of Neuroinflammation|August 17, 2019
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNAJudith Derdelinckx, María José Mansilla, Maxime De Laere, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Brain : a Journal of Neurology|December 18, 2015
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohortSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Neurology|November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohortIlse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neuropathologica Communications|November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brainsJonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Acta Neurologica Belgica|October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical AssociationJan Versijpt, Mark Tant, Ingo Beyer, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
Archives of Neurology|October 10, 2007
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder familyNathalie Brouwers, Karen Nuytemans, Julie van der Zee, et al.
Journal of Neuroinflammation|August 17, 2019
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNAJudith Derdelinckx, María José Mansilla, Maxime De Laere, et al.
Neurobiology of Aging|April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder familyEline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
JAMA Neurology|January 23, 2013
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohortTim Van Langenhove, Julie van der Zee, Ilse Gijselinck, et al.
Pageof 18